Aduro Biotech (ADRO) Tops Q4 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Aduro Biotech Announces Fourth Quarter and Full Year 2015 Financial Results
March 8, 2016 4:06 PM ESTBERKELEY, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the year ended December 31, 2015. Net loss was $39.2 million for the year ended December 31, 2015, or $0.88 per share, compared to a net loss of $17.0 million, or $53.06 per share for the year ended December 31, 2014.Â
Cash, cash equivalents and marketable securities totaled $431.0 million at December 31, 2015, compared to $119.5 million at December 31, 2014.Â
2015 was a banner year for Aduro, said Stephen T. Isaacs, chairman, president and chief executive officer of Aduro. We made tremendous progress on all fronts and are now uniquely positioned in the... More
Aduro Biotech to Present at ROTH Conference
March 7, 2016 4:05 PM ESTBERKELEY, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual ROTH Conference in Laguna Niguel, CA on Monday, March 14, 2016, at 1:00 pm Pacific Time.
To access the live webcast and subsequent archived recording of this and the companys other... More
